Reduced-Fluence Photodynamic Therapy Combined With Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
- 20 January 2012
- journal article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 153 (5), 873-882.e2
- https://doi.org/10.1016/j.ajo.2011.09.031
Abstract
No abstract availableFunding Information
- Yeungnam University
This publication has 39 references indexed in Scilit:
- Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathyActa Ophthalmologica, 2009
- Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patientsJapanese Journal of Ophthalmology, 2008
- Clinical Characteristics of Exudative Age-related Macular Degeneration in Japanese PatientsAmerican Journal of Ophthalmology, 2007
- Polypoidal choroidal vasculopathy: Angiographic characterization of the network vascular elements and a new treatment paradigmProgress in Retinal and Eye Research, 2005
- Polypoidal choroidal vasculopathy in elderly Chinese patientsAlbrecht von Graefes Archiv für Ophthalmologie, 2004
- Polypoidal choroidal vasculopathySurvey of Ophthalmology, 2004
- Polypoidal Choroidal VasculopathyAmerican Journal of Ophthalmology, 2003
- Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachmentsBritish Journal of Ophthalmology, 2000
- Polypoidal Choroidal Vasculopathy and Neovascularized Age-related Macular DegenerationAmerican Journal of Ophthalmology, 1999
- IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)Retina, 1990